Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ZyVersa Therapeutics, Inc. (ZVSA)
Weston, FL, US
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 EPS Ana. |
Dec 2027 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
— – —
|
—
— – —
|
35.00M
35.00M – 35.00M
|
| EBITDA |
-9.14B
|
-25.29M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-9.15B
|
-25.29M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-9.41B
est: -13.80M (-68,124.6%)
|
-24.95M
est: -7.34B (+99.7%)
|
-392.43B
-392.43B – -392.43B
-5,249.6% YoY
|
-530.79B
-530.79B – -530.79B
-35.3% YoY
|
-666.77B
-666.77B – -666.77B
-25.6% YoY
|
| SGA |
7.36B
|
5.73B
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-8.48
est: -12.43 (+31.8%)
|
-4.18
est: -1.23 (-239.8%)
|
-65.80
-65.80 – -65.80
-5,249.6% YoY
|
-89.00
-89.00 – -89.00
-35.3% YoY
|
-111.80
-111.80 – -111.80
-25.6% YoY
|
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZVSA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
